CANS Risk Management & Mitigation 3

Question 1

A patient presents with erythema, warmth, and purulent discharge at a recent filler injection site. The most likely diagnosis is:

Accepted Answer

Biofilm infection

Answer

Purulent discharge with erythema and warmth weeks post-injection suggests biofilm-associated bacterial infection requiring antibiotic therapy.

Question 2

To reduce the risk of intravascular injection during filler treatments, which technique is MOST recommended?

Accepted Answer

Aspirate before injecting and use a slow, retrograde technique

Answer

Aspiration before injection, slow delivery, and retrograde threading reduce the likelihood of inadvertent intravascular placement.

Question 3

A patient on anticoagulation therapy requests neurotoxin treatment. The appropriate risk management action is to:

Accepted Answer

Proceed after informing the patient of increased bruising risk and documenting consent

Answer

Neurotoxin can generally be safely administered to anticoagulated patients after informed consent, as intravascular injection is not a primary risk with toxin.

Question 4

Which cooling strategy best minimizes bruising and discomfort risk before filler injections?

Accepted Answer

Topical anesthetic cream applied 45–60 minutes before

Answer

Topical anesthetic applied 45–60 minutes prior reduces pain and procedural movement that contributes to bruising and inadvertent vessel trauma.

Question 5

What is the PRIMARY role of the CANS certification in risk management?

Accepted Answer

It demonstrates advanced competency in aesthetic nursing to reduce patient harm

Answer

CANS certification validates advanced knowledge and skills in aesthetic nursing, directly supporting safer patient outcomes and reduced adverse event risk.

(CANS) Certified Aesthetic Nurse Specialist Practice Test

(CANS) Certified Aesthetic Nurse Specialist Practice Test

CANS Risk Management & Mitigation 3